Conférence scientifique | Centre de recherche du CHU Sainte-Justine
Kjersti Aagaard, MD, PhD, FACOG
Chaire Henry et Emma Meyer en obstétrique et gynécologie, professeure et vice-président de la recherche, Département d'obstétrique et de gynécologie, Division de la médecine maternelle et fœtale, Baylor College of Medicine et Texas Children's Hospital
After completing her fellowship at the University of Utah, Dr. Aagaard established her independent laboratory and clinical and translational research teams at Baylor College of Medicine in 2007. Dr. Aagaard’s highly collaborative laboratory and clinical research programs are dedicated to (1) discovering the genomic, epigenomic, and metagenomic mechanisms underlying perinatal health and disease, and (2) executing clinical trials to bring these discoveries to the bedside of pregnant women and their infants. This application serves as a natural extension to four major focuses of their research program: (1) molecular mechanisms regulating placentation, and implications for pregnancy health and perinatal disorders, (2) the effect of in utero exposures on the fetal epigenome, (3) identifying the interplay of environmental exposures and genomic and epigenomic mechanisms involved in perinatal disorders and notably preterm birth, and (4) understanding the role of the microbiome in perinatal health (emphasizing preterm birth) with metagenomic interrogations. Dr. Aagaard is currently funded by, or recently completed funded work with: NIH, the Burroughs Welcome Fund Preterm Birth Initiative, the Gates Foundation/USAIDS (Malawi), Thrasher Foundation, and March of Dimes. Their lab work has been previously recognized with receipt of the NIH Directors New Innovator Award (2007) and the Michael E. Debakey Medal for Excellence in Research (2015). Her lab is dedicated to training upcoming generations of translational scientists, particularly physician scientists with an interest in identifying molecular mechanisms driving fetal programming and preterm birth.